Integrated experimental and computational study of a novel indenonaphthodiazepine[5.3.3]propellane as a potential inhibitor of Mcl-1

Myeloid cell leukemia-1 (Mcl-1) is a key anti-apoptotic protein that drives resistance to chemotherapy, making it a critical oncology target.